Tacalcitol Chemical Properties

Boiling point:

565.0±50.0 °C(Predicted)

Density 

1.06

storage temp. 

Sealed in dry,Store in freezer, under -20°C

solubility 

20mg/mL in DMSO, 20mg/mL in DMF, 20mg/mL in Ethanol

pka

14.43±0.40(Predicted)

form 

Powder

CAS DataBase Reference

57333-96-7(CAS DataBase Reference)

Tacalcitol Usage And Synthesis

Description

Tacalcitol, the second vitamin D analog developed as a topical antipsoriatic, was introduced for keratosis, psoriasis, ichthyosis, pityriasis rubra pilaris and palmoplantar pustulosis and keratoderma. It shows improvement in appearance of skin lesions for psoriasis patients without significant side effects. In patients with psoriasis vulgaris, it effectively inhibits keratinocyte growth. Some in vitro studies have shown that tacalcitol inhibits interleukin-1-α-induced granulocyte macrophage colony-stimulating-factor mRNA expression of the human dermal microvascular endothelial cells, which may be involved in mediation of angioproliferation in skin inflammation.

Originator

Teijin (Japan)

Uses

Tacalcitol is a synthetic vitamin D3 analog.

Definition

ChEBI: Tacalcitol is a hydroxy seco-steroid that is calciol which carries hydroxy groups at positions 1S and 24R. It is a vitamin D3 analog which is used for the treatment of psoriasis vulgaris in adults, especially on the scalp. It has a role as an antipsoriatic, a vitamin D receptor agonist and an antineoplastic agent. It is a member of D3 vitamins, a hydroxy seco-steroid, a secondary alcohol and a seco-cholestane. It is functionally related to a calciol.

brand name

Bonalfa

Safety Profile

A poison by ingestion, subcutaneous, and intravenous routes. When heated to decomposition it emits acrid smoke and irritating vapors,

Tacalcitol(57333-96-7)Related Product Information

• Tacalcitol monohydrate
• 1,2-DIMETHYLENE-CYCLOHEXANE
• VitaMin D4
• Tacalcitol